Identification of Microorganisms using Nucleic Acid Probes
Customize your policy alerts
Sign up for all Oscar Health policy alerts
Know when Oscar Health releases new policies or updates existing guidance.
Monitor payer policy activity
Coverage criteria for individual direct-probe, amplified-probe, and quantification nucleic acid tests used to identify microorganisms, subject to benefit, medical necessity, authorization, state, and coding requirements.
The policy update added CPT codes 87594 and 87638 to the Applicable CPT/HCPCS Procedure Codes section.
The policy background, guidelines, and evidence-based scientific references were updated.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.